| Date Filed | Type | Description |
| 06/08/2023 |
4
| Santel Donald J (Director) has filed a Form 4 on Aerovate Therapeutics, Inc.|
Txns:
| Granted 12,500 options to buy
@ $16.3, valued at
$203.8k
|
|
| 01/23/2023 |
4
| Santel Donald J (Director) has filed a Form 4 on Aerovate Therapeutics, Inc.|
Txns:
| Granted 25,000 options to buy
@ $23.44, valued at
$586k
Granted 2,519 options to buy
@ $23.44, valued at
$59k
|
|
| 01/23/2023 |
3
| Santel Donald J (Director) has filed a Form 3 on Aerovate Therapeutics, Inc. |
| 01/04/2023 |
4
| Santel Donald J (Director) has filed a Form 4 on Oyster Point Pharma, Inc.|
Txns:
| Unknown transaction of 5,489 shares
@ $0
Disposed/sold 8,198 shares
@ $0
Disposed/sold 15,170 options to buy
@ $14.25, valued at
$216.2k
Disposed/sold 5,359 options to buy
@ $3.63, valued at
$19.5k
|
|
| 06/08/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/13/2021 |
4
| Santel Donald J (Former Director) has filed a Form 4 on Surrozen, Inc./DE|
Txns:
| Granted 30,000 shares
@ $0
Disposed/sold 30,000 options to buy
@ $0 |
|
| 08/03/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/03/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 11/18/2020 |
3
| Santel Donald J (Director) has filed a Form 3 on Consonance-HFW Acquisition Corp. |
| 05/01/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 07/25/2012 |
3
| Form 3 - Initial statement of beneficial ownership of securities |
| 07/05/2011 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 02/23/2010 |
3
| Form 3 - Initial statement of beneficial ownership of securities |